Gabapentin
- Product NDC
- 60760-517
- 11-digit product format
- 607600517
- Labeler code
- 60760
- Product ID
- 60760-517_552a1f12-4de7-74bc-e063-6294a90a1af1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA205101
- Marketing category
- ANDA
- Marketing start
- 2021-07-06
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 60760-517 | 60760-517-60 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60760-517-60 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60760-517-60 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 60760-517-60 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 60760-517-60 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 60760-517-60 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 60760-517-60 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 60760-517-60 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 60760-517-60 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 60760-517-60 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 60760-517-60 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 60760-517-60 | 367a005e9d99… | 383a685ebd0f… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205101-001 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | |
| A205101-002 | GABAPENTIN | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A205101-001 | AB1 |
| A205101-002 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2016-02-04 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2016-02-04 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2016-02-04 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2016-02-04 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2016-02-04 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2016-02-04 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2016-02-04 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2016-02-04 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A205101-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2016-02-04 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A205101-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2016-02-04 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A205101-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205101-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A205101-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205101-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A205101-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205101-002 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205101-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205101-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A205101-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205101-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205101-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205101-002 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205101-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205101-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205101-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205101-002 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205101-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205101-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205101-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205101-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205101-001 | AB1 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205101-002 | AB1 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A205101-001 | AB1 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A205101-002 | AB1 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205101-001 | AB1 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205101-002 | AB1 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205101-001 | AB1 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205101-002 | AB1 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205101-001 | AB1 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205101-002 | AB1 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A205101-001 | AB1 | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A205101-002 | AB1 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205101-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205101-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A205101-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A205101-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A205101-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A205101-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A205101-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A205101-002 | AB | 1 | 74a2ff9319b5… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gabapentin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GABAPENTIN | 800 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6CW7F3G59X | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310434 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c85ae572-9893-629e-e053-2995a90a23fc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60760-517-30 | Gabapentin | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 3 | |
| 60760-517-60 | Gabapentin | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 3 | |
| 60760-517-90 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60760-517-30 | EA - Each | 60760-517 | d458ba00-dfa4-453c-9463-b953680cbf57 | 1 | 2026-01-08 |
| 60760-517-60 | EA - Each | 60760-517 | b1871022-998a-49ab-8b50-d1e05d5cc82e | 1 | 2022-07-06 |
| 60760-517-90 | EA - Each | 60760-517 | a48117e8-f4b8-4341-b797-4cb7b86744c1 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 7a2aa696-7dac-4d03-916a-374b61a255b5 | 2024-02-16 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 79cd9dea-e7d0-44db-afba-964cb99f32b6 | 2024-01-31 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | f9bf87e4-5499-4dd7-a0c1-16025a718d14 | 2024-01-09 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9c96b488-19bd-431e-af9a-b313ffd9eaae | 2023-10-01 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | af62bb7e-162e-4e2a-8eb0-d50f66678707 | 2023-09-22 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 35004f84-90ae-45f0-a2ba-653dec507229 | 2023-03-01 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9d544944-ea95-42e1-8c65-9e442437f0ee | 2022-10-10 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | c18d9d06-f796-4eb7-8fd5-1de4ebb95439 | 2022-07-07 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | b67b7865-df64-429a-9550-5333b9c713ea | 2022-04-01 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2fb2233f-9152-4630-ab39-51a0cda7e5ca | 2022-04-01 | Warnings, Adverse reactions | 205101 ANDA205101 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2b76955c-52a4-4026-b286-3da1112fe989 | 2022-04-01 | Warnings, Adverse reactions | 205101 ANDA205101 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310434 | gabapentin 800 MG Oral Tablet | PSN | c85ae572-9893-629e-e053-2995a90a23fc | 3 |
| 310434 | gabapentin 800 MG Oral Tablet | SCD | c85ae572-9893-629e-e053-2995a90a23fc | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60760-517-30 | 60760051730 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-517-30) | 30 tablet | 2025-12-12 | No | No | Current | |
| 60760-517-60 | 60760051760 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-517-60) | 60 tablet | 2021-07-06 | 0000-00-00 | No | No | Current |
| 60760-517-90 | 60760051790 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-517-90) | 90 tablet | 2025-12-12 | No | No | Current |